HL7 FHIR Implementation Guide: Breast Cancer Data, Release 1 - US Realm (Draft for Comment 2)
This page is part of the Breast Cancer Data Logical Models and FHIR Profiles (v0.2.0: STU 1 Draft) based on FHIR R3. . For a full list of available versions, see the Directory of published versions 
Definitions for cimi-entity-MedicationIngredient-model.
| cimi-entity-MedicationIngredient-model | |
| Definition | Specifies an material component in a medication. |
| Control | 0..* |
| cimi-entity-MedicationIngredient-model.value[x] | |
| Definition | Choice of types representing specifies an material component in a medication. |
| Control | 1..1 |
| Type | Choice of: Coding, Reference(SubstanceModel | MedicationModel) |
| [x] Note | See Choice of Data Types for further information about how to use [x] |
| cimi-entity-MedicationIngredient-model.ingredientAmount | |
| Definition | The amount of an ingredient in a mixture, as a ratio. For example, 250 mg per tablet is expressed as a ratio where the numerator is 250mg and the denominator is 1 tablet. |
| Control | 1..1 |
| Type | http://hl7.org/fhir/us/breastcancer/StructureDefinition/shr-core-Ratio-model |
| cimi-entity-MedicationIngredient-model.isActiveIngredient | |
| Definition | True if the ingredient is an active ingredient in the medication. |
| Control | 1..1 |
| Type | boolean |